Source: International Congress 2015 – Inflammation and remodelling in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mariana Kulynych-Miskiv (Galych, Ukraine), Mariana Kulynych-Miskiv, Mykola Ostrovskyy, Oleksandr Varunkiv, Iryna Savelikhina, Olena Deltsova, Vasyl Miskiv, Sergiy Gerashchenko. Protective effects of tiotropium bromide on the morphological remodeling of the bronchi on the neocollagenesis processes in patients with moderate COPD during exacerbation. Eur Respir J 2015; 46: Suppl. 59, 3919

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Changes of IL-6 level in bronchoalveolar fluid in patients with acute exacerbation of COPD before and after the treatment with tiotropium bromide, and its significance Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Relation of lung function with bronchoalveolar lavage cell findings in mild to moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002 Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 The influence of tiotropium bromide on neutrophiles function of bronchial region in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010 Phenotype of lung lymphocytes in bronchial asthma and chronic bronchitis patients in bronchial (BLF) and alveolar (ALF) lavage fluids Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Influence of tiotropium bromid on airway inflammation and symptom in COPD patients Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Characteristics of endobronchial dendritic cells in patients with stable COPD Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL Source: International Congress 2014 – Translational studies in COPD Year: 2014 Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007